Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000892569-95-000068
Filing Date
1995-03-23
Accepted
1995-03-23 00:00:00
Documents
8
Period of Report
1994-12-31
SROs
NYSE

Document Format Files

Seq Description Document Type Size
1 ALLERGAN INC -- FORM 10-K ENDING 12/31/94 10-K 78516
2 AMEND. #1 TO CREDIT AGREMENT DATED 9/30/94 EX-10.9 11491
3 EXECUTIVE DEFERRED COMPENSATION PLAN DATED 1/1/95 EX-10.15 51945
4 STATEMENT RE COMPUTATION OF EARNINGS PER SHARE EX-11 2175
5 ANNUAL REPORT TO SHAREHOLDERS FOR FYE 12/31/94 EX-13 104292
6 LIST OF SUBSIDIARIES OF THE COMPANY EX-21 5586
7 CONSENT OF KPMG PEAT MARWICK EX-23 1260
8 FINANCIAL DATA SCHEDULE EX-27 2402
  Complete submission text file 0000892569-95-000068.txt   259903
Mailing Address 2525 DUPONT DRIVE IRVINE CA 92715
Business Address 2525 DUPONT DR IRVINE CA 92715 7147524500
ALLERGAN INC (Filer) CIK: 0000850693 (see all company filings)

EIN.: 951622442 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-10269 | Film No.: 95522752
SIC: 2834 Pharmaceutical Preparations